Glen E. Palmer
Impact in
- Infectious Diseases top 1%
- Antifungal resistance and susceptibility
- Microbiology top 2%
- Reproductive tract infections research
- Antimicrobial Peptides and Activities
Papers in
-
- Antifungal resistance and susceptibility 42
- Epidemiology 31
- Fungal Infections and Studies 23
- Pneumocystis jirovecii pneumonia detection and treatment 7
- Autophagy in Disease and Therapy 4
- Co-authors
- Brian M. Peters (13 shared papers)Katherine S. Barker (9 shared papers)Joy Sturtevant (6 shared papers)P. David Rogers (8 shared papers)Paul L. Fidel (6 shared papers)Jeffrey M. Rybak (5 shared papers)Mairi C. Noverr (3 shared papers)Karen Eberle (8 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (9 papers)Infection and Immunity (8 papers)mBio (5 papers)mSphere (5 papers)Eukaryotic Cell (4 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Glen E. Palmer
52 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 95
- Infectious Diseases 1.1k
- Microbiology 263
- Epidemiology 816
- Periodontics 51
- Pharmacology 122
Countries citing papers authored by Glen E. Palmer
This map shows the geographic impact of Glen E. Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glen E. Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glen E. Palmer more than expected).
Fields of papers citing papers by Glen E. Palmer
This network shows the impact of papers produced by Glen E. Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glen E. Palmer. The network helps show where Glen E. Palmer may publish in the future.
Co-authors
The 25 scholars most cited alongside Glen E. Palmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 142 | |
| 2 | 2017 | 142 | |
| 3 | 2013 | 141 | |
| 4 | 2019 | 112 | |
| 5 | 2012 | 84 | |
| 6 | 2006 | 73 | |
| 7 | 2013 | 60 | |
| 8 | 2013 | 57 | |
| 9 | 2003 | 56 | |
| 10 | 2021 | 52 | |
| 11 | 2019 | 47 | |
| 12 | 2017 | 45 | |
| 13 | 2018 | 44 | |
| 14 | 2014 | 44 | |
| 15 | 2021 | 41 | |
| 16 | 2008 | 30 | |
| 17 | 2015 | 28 | |
| 18 | 2009 | 27 | |
| 19 | 2020 | 26 | |
| 20 | 2013 | 23 |
About Glen E. Palmer
Glen E. Palmer is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Pharmacology and Microbiology, having authored 53 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (42 papers), Fungal Infections and Studies (23 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers), Peptidase Inhibition and Analysis (5 papers), Microbial Natural Products and Biosynthesis (5 papers), Fungal and yeast genetics research (4 papers), Fungal Biology and Applications (4 papers) and Autophagy in Disease and Therapy (4 papers). The work is most often cited by research in Infectious Diseases (1.1k citations), Microbiology (263 citations), Epidemiology (816 citations), Periodontics (51 citations) and Pharmacology (122 citations). Glen E. Palmer has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Brian M. Peters, Katherine S. Barker, Joy Sturtevant, P. David Rogers, Paul L. Fidel, Jeffrey M. Rybak, Mairi C. Noverr, Karen Eberle, Hubertine M. E. Willems and Michelle N. Kelly. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Infection and Immunity, mBio, mSphere and Eukaryotic Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.